DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.
Companies / C••••••••• C••••••••• C••••••• I•••
C••••••••• C••••••••• C••••••• I•••
Stage unknownLos Angeles, CAPharmaceuticals
Facts
Financing history
1 rounds
- May 1, 2026Form D equity offering · $4.9M (form d sold) · 4 investorsFact Form D · “••• Locked”
Investors on record
0 edges
No named investor yet.
People
3 officers, 0 directors
- A••• F••••••• Chief Operating Officer and Corporate Secretary sec.gov
- J••••• L••• Chief Executive Officer sec.gov
- T•••• T••• Chief Financial Officer and Treasurer sec.gov
Timeline
1
- May 12, 2026••• LockedForm D filed Fact Form D
Evidence
15 observations
Every observation on this company
- Entity type: Corporation May 12, 2026 Fact Form D
- Form D industry group: Pharmaceuticals May 12, 2026 Fact Form D
- Amendment: false May 12, 2026 Fact Form D
- Revenue range (Form D): Decline to Disclose May 12, 2026 Fact Form D
- Incorporated: withinFiveYears May 12, 2026 Fact Form D
- Jurisdiction: Delaware May 12, 2026 Fact Form D
- Amount sold (Form D): $4.9M May 12, 2026 Fact Form D
- Offering amount (Form D): $14.5M May 12, 2026 Fact Form D
- Exemptions: 06b May 12, 2026 Fact Form D
- First sale: 2026-05-01 May 12, 2026 Fact Form D
- Investors (Form D): 4 May 12, 2026 Fact Form D
- Minimum investment (Form D): 0 May 12, 2026 Fact Form D
- Securities offered: equity,option May 12, 2026 Fact Form D
- Office address: ••• Locked May 12, 2026 Fact Form D
- Year of incorporation: 2026 May 12, 2026 Fact Form D